logo

[breadcrumb_custom]

Prime Medicine Inc Inc. (PRME) Price Performance: A Fundamental Analysis Perspective

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded a decrease of -34.54%. However, over the last six months, the performance has been stronger by -33.64%. The price of PRME decreased -33.87% over the last 30 days. And in the last five days, it has fallen by -12.91%.

Prime Medicine Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $17.20 on 06/07/23, while the lowest price for the same period was registered at $5.54 on 10/27/23.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

52-week price history of PRME Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Prime Medicine Inc’s current trading price is -66.28% away from its 52-week high, while its distance from the 52-week low is 4.69%. The stock’s price range during this period has varied between$5.54 and $17.20. The Prime Medicine Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.26 million for the day, a figure considerably higher than their average daily volume of 0.66 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Prime Medicine Inc (PRME) has experienced a quarterly decline of -33.79% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 695.65M and boasts a workforce of 234 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 7.67, with a change in price of -2.51. Similarly, Prime Medicine Inc recorded 633,112 in trading volume during the last 100 days, posting a change of -30.20%.

PRME’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PRME stands at 0.10. Similarly, the long-term debt-to-equity ratio is also 0.03.

PRME Stock Stochastic Average

As of today, Prime Medicine Inc’s raw stochastic average for the last 50 days stands at 0.25%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 0.36%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 5.44% and 11.30%, respectively.

On Key

Related Posts